BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Y, Hoerle R, Ehrich M, Zhang C. Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability. Acta Biomater 2015;28:149-59. [PMID: 26428192 DOI: 10.1016/j.actbio.2015.09.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Ghitman J, Biru EI, Stan R, Iovu H. Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine. Materials & Design 2020;193:108805. [DOI: 10.1016/j.matdes.2020.108805] [Cited by in Crossref: 32] [Cited by in F6Publishing: 5] [Article Influence: 16.0] [Reference Citation Analysis]
2 Vartak A, Sucheck SJ. Recent Advances in Subunit Vaccine Carriers. Vaccines (Basel) 2016;4:E12. [PMID: 27104575 DOI: 10.3390/vaccines4020012] [Cited by in Crossref: 117] [Cited by in F6Publishing: 95] [Article Influence: 19.5] [Reference Citation Analysis]
3 Hu Y, Smith D, Frazier E, Zhao Z, Zhang C. Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine. Mol Pharm 2021;18:1293-304. [PMID: 33497574 DOI: 10.1021/acs.molpharmaceut.0c01153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci 2020;7:193. [PMID: 32974385 DOI: 10.3389/fmolb.2020.00193] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
5 Lou S, Zhao Z, Dezort M, Lohneis T, Zhang C. Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer. ACS Omega 2018;3:9210-9. [PMID: 30197996 DOI: 10.1021/acsomega.8b00949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
6 Yang F, Li A, Liu H, Zhang H. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Des Devel Ther 2018;12:3321-33. [PMID: 30323564 DOI: 10.2147/DDDT.S176879] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Date T, Nimbalkar V, Kamat J, Mittal A, Mahato RI, Chitkara D. Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics. J Control Release 2018;271:60-73. [PMID: 29273320 DOI: 10.1016/j.jconrel.2017.12.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
8 Samimi S, Maghsoudnia N, Eftekhari RB, Dorkoosh F. Lipid-Based Nanoparticles for Drug Delivery Systems. Characterization and Biology of Nanomaterials for Drug Delivery. Elsevier; 2019. pp. 47-76. [DOI: 10.1016/b978-0-12-814031-4.00003-9] [Cited by in Crossref: 14] [Article Influence: 4.7] [Reference Citation Analysis]
9 Hamdi M, Abdel-Bar HM, Elmowafy E, Al-Jamal KT, Awad GAS. An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect. PLoS One 2020;15:e0227231. [PMID: 31923260 DOI: 10.1371/journal.pone.0227231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
10 Peng Y, Bariwal J, Kumar V, Tan C, Mahato RI. Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment. Adv Therap 2020;3:1900136. [DOI: 10.1002/adtp.201900136] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
11 Bose RJ, Lee SH, Park H. Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications. Biomater Res 2016;20:34. [PMID: 27807476 DOI: 10.1186/s40824-016-0081-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
12 Wang YY, Zhang DD, Kong YY, Shao LL, Zhang FY, Gao Y, Mu X, Wang J, Li HF, Yu SQ, Xu Q. CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells. Colloids Surf B Biointerfaces 2016;145:716-27. [PMID: 27289313 DOI: 10.1016/j.colsurfb.2016.05.088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
13 Al-Thamarani S, Gardouh A. Enhanced oral bioavailability and gastroprotective effect of ibuprofen through mixed polymer-lipid nanoparticles. Ther Deliv 2021;12:363-74. [PMID: 33849297 DOI: 10.4155/tde-2020-0125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhao Z, Hu Y, Harmon T, Pentel PR, Ehrich M, Zhang C. Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins. Nanomedicine 2018;14:1655-65. [PMID: 29719216 DOI: 10.1016/j.nano.2018.04.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Jacob S, Nair AB, Boddu SHS, Gorain B, Sreeharsha N, Shah J. An Updated Overview of the Emerging Role of Patch and Film-Based Buccal Delivery Systems. Pharmaceutics 2021;13:1206. [PMID: 34452167 DOI: 10.3390/pharmaceutics13081206] [Reference Citation Analysis]
16 Sainz V, Moura LIF, Peres C, Matos AI, Viana AS, Wagner AM, Vela Ramirez JE, S Barata T, Gaspar M, Brocchini S, Zloh M, Peppas NA, Satchi-Fainaro R, F Florindo H. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma. Acta Biomater 2018;76:193-207. [PMID: 29940370 DOI: 10.1016/j.actbio.2018.06.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
17 Mittal NK, Mandal B, Balabathula P, Setua S, Janagam DR, Lothstein L, Thoma LA, Wood GC. Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies. Pharmaceutics 2018;10:E50. [PMID: 29662041 DOI: 10.3390/pharmaceutics10020050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Dana P, Bunthot S, Suktham K, Surassmo S, Yata T, Namdee K, Yingmema W, Yimsoo T, Ruktanonchai UR, Sathornsumetee S, Saengkrit N. Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer. Colloids Surf B Biointerfaces 2020;196:111270. [PMID: 32777659 DOI: 10.1016/j.colsurfb.2020.111270] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Ma P, Li T, Xing H, Wang S, Sun Y, Sheng X, Wang K. Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: In vitro and in vivo evaluation. Biomed Pharmacother 2017;89:689-95. [PMID: 28267672 DOI: 10.1016/j.biopha.2017.01.175] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
20 Abdou EM, Fayed MAA, Helal D, Ahmed KA. Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted β-Sitosterol against CCl4 induced hepatotoxicity in rats. Sci Rep 2019;9:19779. [PMID: 31875004 DOI: 10.1038/s41598-019-56320-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
21 Hu Y, Smith D, Frazier E, Hoerle R, Ehrich M, Zhang C. The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine. Biomaterials 2016;106:228-39. [PMID: 27569868 DOI: 10.1016/j.biomaterials.2016.08.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
22 Kamel NM, Helmy MW, Abdelfattah E, Khattab SN, Ragab D, Samaha MW, Fang J, Elzoghby AO. Inhalable Dual-Targeted Hybrid Lipid Nanocore–Protein Shell Composites for Combined Delivery of Genistein and All-Trans Retinoic Acid to Lung Cancer Cells. ACS Biomater Sci Eng 2020;6:71-87. [DOI: 10.1021/acsbiomaterials.8b01374] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
23 Hashemi M, Shamshiri A, Saeedi M, Tayebi L, Yazdian-Robati R. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs. Arch Biochem Biophys 2020;691:108485. [PMID: 32712288 DOI: 10.1016/j.abb.2020.108485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhao Z, Hu Y, Hoerle R, Devine M, Raleigh M, Pentel P, Zhang C. A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy. Nanomedicine 2017;13:443-54. [PMID: 27520729 DOI: 10.1016/j.nano.2016.07.015] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
25 Kamel NM, Helmy MW, Samaha MW, Ragab D, Elzoghby AO. Multicompartmental lipid–protein nanohybrids for combined tretinoin/herbal lung cancer therapy. Nanomedicine 2019;14:2461-79. [DOI: 10.2217/nnm-2019-0090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Scopel R, Falcão MA, Cappellari AR, Morrone FB, Guterres SS, Cassel E, Kasko AM, Vargas RMF. Lipid-polymer hybrid nanoparticles as a targeted drug delivery system for melanoma treatment. International Journal of Polymeric Materials and Polymeric Biomaterials 2022;71:127-38. [DOI: 10.1080/00914037.2020.1809406] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
27 Hu Y, Zhao Z, Harmon T, Pentel PR, Ehrich M, Zhang C. Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines. Biomaterials 2018;182:72-81. [PMID: 30107271 DOI: 10.1016/j.biomaterials.2018.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
28 Omar SH, Osman R, Mamdouh W, Abdel-Bar HM, Awad GAS. Bioinspired lipid-polysaccharide modified hybrid nanoparticles as a brain-targeted highly loaded carrier for a hydrophilic drug. Int J Biol Macromol 2020;165:483-94. [PMID: 32987085 DOI: 10.1016/j.ijbiomac.2020.09.170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Devrim B, Kara A, Vural İ, Bozkır A. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation. Drug Dev Ind Pharm 2016;42:1865-76. [PMID: 27091346 DOI: 10.1080/03639045.2016.1180392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
30 Zhao Z, Hu Y, Harmon T, Pentel P, Ehrich M, Zhang C. Effect of Adjuvant Release Rate on the Immunogenicity of Nanoparticle-Based Vaccines: A Case Study with a Nanoparticle-Based Nicotine Vaccine. Mol Pharm 2019;16:2766-75. [PMID: 31075204 DOI: 10.1021/acs.molpharmaceut.9b00279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pukale SS, Sharma S, Dalela M, Singh AK, Mohanty S, Mittal A, Chitkara D. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice. Acta Biomaterialia 2020;115:393-409. [DOI: 10.1016/j.actbio.2020.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Wang J, Hu X, Xiang D. Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Deliv 2018;25:1319-27. [PMID: 29869539 DOI: 10.1080/10717544.2018.1477857] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
33 Bose RJ, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S, Thandavarayan RA. Lipid–polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges. Drug Discovery Today 2017;22:1258-65. [DOI: 10.1016/j.drudis.2017.05.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
34 Thakur NS, Mandal N, Patel G, Kirar S, Reddy YN, Kushwah V, Jain S, Kalia YN, Bhaumik J, Banerjee UC. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy. Nanomedicine 2021;33:102368. [PMID: 33548477 DOI: 10.1016/j.nano.2021.102368] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Golan-Paz S, Frizzell H, Woodrow KA. Cross-Platform Comparison of Therapeutic Delivery from Multilamellar Lipid-Coated Polymer Nanoparticles. Macromol Biosci 2019;19:e1800362. [PMID: 30589222 DOI: 10.1002/mabi.201800362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Dong W, Wang X, Liu C, Zhang X, Zhang X, Chen X, Kou Y, Mao S. Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin. International Journal of Pharmaceutics 2018;547:499-505. [DOI: 10.1016/j.ijpharm.2018.05.076] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
37 Hu Y, Smith D, Zhao Z, Harmon T, Pentel PR, Ehrich M, Zhang C. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine. Nanomedicine 2019;20:102023. [PMID: 31181264 DOI: 10.1016/j.nano.2019.102023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]